NCT03940963 - Study of AxoGuard® Nerve Cap and Neurectomy for Treatment of Symptomatic Neuroma & Prevention of Recurrent Neuroma Pain | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 10, 2018

Primary Completion Date

July 17, 2023

Study Completion Date

July 17, 2023

Conditions

Symptomatic NeuromaMorton's NeuromaChronic Nerve Pain

Interventions

DEVICE

AxoGuard® Nerve Cap

Entubulation of the nerve stump into the AxoGuard® Nerve Cap following surgical excision of symptomatic neuroma

PROCEDURE

Standard Neurectomy

Surgical excision of symptomatic neuroma

Trial Locations (11)

EHI Clinical Research, Roswell

Anastasia Medical Group, Saint Augustine

The Ohio State University, Columbus

OrthoIllinois, Rockford

Gateway Clinical Trials, O'Fallon

Foot and Ankle Center of Illinois, Springfield

JPS Health Network, Fort Worth

Complete Foot and Ankle Care of North Texas, Denton

Austin Foot and Ankle Specialists, Austin

Foot & Ankle Institute, St. George

New Hope Podiatry Group, Los Angeles